AI in drug discovery: predictions for 2026 - Drug Target Review
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxNZ2MzRF8zY1doY290U29sdkhodndvQ1B0TXZFeUZheXJnck9yWkFLYmZKYkk5Y25QWlQzSjJyNFdUcDBIbEJSWWhMa2Vxa2IwTTA5X1VLaVZDX1hDY2d4TGZSazZFeDhPN3dGZ19iRzBxVG9pQ3cyOUZJU1FsdVdrdkZld0JrbEpvUndBUEYtUWd2Nk5N?oc=5" target="_blank">AI in drug discovery: predictions for 2026</a> <font color="#6f6f6f">Drug Target Review</font>
Could not retrieve the full article text.
Read on GNews AI drug discovery →Sign in to highlight and annotate this article
Conversation starters
Daily AI Digest
Get the top 5 AI stories delivered to your inbox every morning.
More about
predictionreview
60% of Consumers Want Approval Gates for AI Spending. Who Builds Them?
Visa just published a study of 2,000 consumers on AI agents and spending. The finding that should dominate every conversation about agentic commerce: 60% of respondents want human approval gates before an AI agent makes purchases on their behalf. Only 27% are comfortable with unlimited AI spending authority. Thirty-six percent say they would trust an AI agent backed by their bank. Twenty-eight percent would trust an independent agent. The paper's own summary: "Trust is the adoption switch." This is empirical confirmation of something that was structurally obvious. The infrastructure to move money is almost ready. The infrastructure to decide whether money should move does not exist. The asymmetry Two days ago, the x402 Foundation launched under the Linux Foundation. Twenty-two founding mem
Knowledge Map
Connected Articles — Knowledge Graph
This article is connected to other articles through shared AI topics and tags.
Discussion
Sign in to join the discussion
No comments yet — be the first to share your thoughts!